HomeCompareCGMLF vs MRK

CGMLF vs MRK: Dividend Comparison 2026

CGMLF yields 215.05% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CGMLF wins by $182.78M in total portfolio value
10 years
CGMLF
CGMLF
● Live price
215.05%
Share price
$0.93
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$182.84M
Annual income
$95,489,191.70
Full CGMLF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CGMLF vs MRK

📍 CGMLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCGMLFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CGMLF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CGMLF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CGMLF
Annual income on $10K today (after 15% tax)
$18,279.57/yr
After 10yr DRIP, annual income (after tax)
$81,165,812.95/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CGMLF beats the other by $81,157,484.53/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CGMLF + MRK for your $10,000?

CGMLF: 50%MRK: 50%
100% MRK50/50100% CGMLF
Portfolio after 10yr
$91.45M
Annual income
$47,749,494.92/yr
Blended yield
52.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CGMLF
No analyst data
Price Target
$3.23
+247.3% upside vs current
Range: $2.75 — $3.70
Altman Z
45.5
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CGMLF buys
0
MRK buys
0
No recent congressional trades found for CGMLF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCGMLFMRK
Forward yield215.05%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$182.84M$56.8K
Annual income after 10y$95,489,191.70$9,798.13
Total dividends collected$172.98M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst price target$3.23$128.54

Year-by-year: CGMLF vs MRK ($10,000, DRIP)

YearCGMLF PortfolioCGMLF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$32,205$21,505.38$11,206$366.19+$21.0KCGMLF
2$99,188$64,727.92$12,650$502.35+$86.5KCGMLF
3$292,441$186,310.44$14,407$694.19+$278.0KCGMLF
4$826,287$513,374.56$16,585$967.82+$809.7KCGMLF
5$2,239,762$1,355,634.76$19,342$1,363.89+$2.22MCGMLF
6$5,830,779$3,434,234.44$22,913$1,947.19+$5.81MCGMLF
7$14,594,406$8,355,471.88$27,662$2,823.89+$14.57MCGMLF
8$35,161,525$19,545,510.50$34,159$4,173.35+$35.13MCGMLF
9$81,632,138$44,009,306.33$43,337$6,308.80+$81.59MCGMLF
10$182,835,579$95,489,191.70$56,776$9,798.13+$182.78MCGMLF

CGMLF vs MRK: Complete Analysis 2026

CGMLFStock

Chalice Mining Limited operates as a mineral exploration and evaluation company. The company explores for gold, copper, cobalt, palladium, platinum group element, and nickel deposits. Its flagship properties include the Julimar Nickel-Copper-Platinum group element project that covers an area of approximately 740 square kilometers located in Avon Region, Western Australia; and the Barrabarra Nickel -Copper- Platinum group element project located in Geraldton. It also holds interest in Hawkstone Nickel-Copper-Cobalt project located in Kimberley and South West Nickel-Copper- Platinum group element project located in Perth, Western Australia. Chalice Mining Limited was incorporated in 2005 and is based in West Perth, Australia.

Full CGMLF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CGMLF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CGMLF vs SCHDCGMLF vs JEPICGMLF vs OCGMLF vs KOCGMLF vs MAINCGMLF vs JNJCGMLF vs ABBVCGMLF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.